期刊
AMERICAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
卷 12, 期 2, 页码 44-53出版社
E-CENTURY PUBLISHING CORP
关键词
Congenital hyperinsulinism; PET/CT; molecular hybrid imaging; DOPA; pediatric
Congenital hyperinsulinism (HI) is a life-threatening condition that requires accurate diagnosis and treatment. Integrated PET/CT scan is a crucial imaging technique that can help differentiate between different forms of HI and guide surgical treatment.
Congenital hyperinsulinism (HI) is a life threatening condition characterized by severe and recurrent episodes of hypoglycaemia due to defects in key genes involved in regulating insulin secretion. The delay in diagnosis and inappropriate management of HI lead to high risk of permanent hypoglycemic brain injury. The management of HI is challenging as each form of HI (focal, diffuse, and atypical) requires its own therapeutic strategy. In HI diagnostic work-up, integrated PET/CT scan is currently the first-line imaging technique allowing to differentiate between diffuse and focal form and, in the latter case, to localize the focus within the pancreas with high precision. Only in focal HI partial pancreatectomy is the treatment of choice and a curative surgical treatment means a real chance of transforming patient's lives and HI patient's future. The aim of this review is to discuss the role of PET/CT imaging in HI scenario, its technical advantages and limitations and how successful surgery is strongly dependent on accurate preoperative assessment (genetic analysis and PET/CT scan). A multidisciplinary approach in HI diagnosis and treatment inside a single team (involving different expertise) allows to manage children safely and properly, supporting their families in an organized care network.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据